Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001146

Drug Information
NameAmphetamine    
SynonymsCID3007; 1-Phenylpropan-2-amin; (S)-.alpha.-Phenylethylamine; 1-Phenyl-2-aminopropane; 3-Phenyl-2-propylamine; Levoamphetamine; Phenethylamine, alpha-methyl-, (+-)-; beta-Phenylisopropylamin [German]; Isoamyne; S(+)-Amphetamine; Allodene; DEA No. 1100; AMPHETAMINE; (+-)-alpha-Methylphenylethylamine; (+-)-alpha-Methylbenzeneethanamine; 300-62-9; levo-Amphetamine; (+-)-alpha-Methylphenethylamine; Fenylo-izopropylaminyl; DL-Amphetamine solution; Simpatina; Benzedrine; Phenethylamine, alpha-methyl-; AC1Q5065; HSDB 3287; LS-1428; beta-Phenylisopropylamine; Oktedrin; Amfetamine (INN); Adderall; Profamina; Anorexide; 60-13-9 (sulfate (2:1)); DivK1c_000991; (+)-.alpha.-Methylphenethylamine; Amfetamina [INN-Spanish]; IDI1_000991; Ortedrine; alpha-Methylphenylethylamine; racemic-Desoxynor-ephedrine; KBio1_000991; Phenedrine; (S)-(+)-.beta.-Phenylisopropylamine; 1-Phenyl-2-amino-propan [German]; Benzebar; ALPHA-METHYL-BENZENEETHANAMIDE (SEE ALSO DL-AMPHETAMINE SULFATE); C07514; 610240_ALDRICH; Isomyn; CHEBI:2679; 610240_FLUKA; NSC27159; L-Amphetamine; .alpha.-Methylphenethylamine, d-form; UNII-CK833KGX7E; Benzeneethanamine, alpha-methyl-, (+-)-; NSC 27159; (+-)-Benzedrine; beta-Aminopropylbenzene; Amfetamin (TN); Anorexine; LS-1148; AMPHETAMINE, (D); Norephedrane; nchembio.284-comp5; Phenamine; WLN: ZY1&1R -D; Benzeneethanamine, .alpha.-methyl-, (.+/-.)-; .alpha.-Methylbenzeneethanamine; 1-Methyl-2-phenylethylamine; Actedron; Percomon; Protioamphetamine; AR-1H6584; Amfetamine; CHEMBL405; .beta.-Phenylisopropylamine; nchembio.2007.55-comp27; .alpha.-Methylphenylethylamine; Phenethylamine, D-.alpha.-methyl-; Fenopromin; Desoxynorephedrine; NINDS_000991; Anfetamina; Phenethylamine, .alpha.-methyl-, (+)-; .beta.-Aminopropylbenzene; Amfetamine [INN:BAN]; Benzeneethanamine, alpha-methyl-; WLN: ZY1&1R; d-.alpha.-Methylphenethylamine; Benzeneethanamine, .alpha.-methyl-; beta-Aminopropylbenzene (VAN); alpha-Methylbenzeneethaneamine; HMS503G03; Amfetamina [Italian]; component of Amodex; Dexedrine; Amsustain; .alpha.-Methylphenethylamine; L000864; Amfetamin; Phenethylamine, .alpha.-methyl-, (.+/-.)-; Amphetamin; 1-Phenyl-2-aminopropane (VAN); 1-Phenyl-2-amino-propan; Fenylo-izopropylaminyl [Polish]; amfetaminum; 17108-96-2; dl-alpha-Methylphenethylamine; Amfetamina; NSC73713; Amfetaminum [INN-Latin]; Amphetamine resin complex; AC1L1EYQ; 96332-84-2; Benzeneethanamine, .alpha.-methyl-, (S)-; Phenethylamine, .alpha.-methyl-; Finam; Elastonon; Amphetamine, its salts, optical isomers, and salts of its optical isomers; .beta.-Phenylisopropylamin; AMPHETAMINE (SEE ALSO: D-AMPHETAMINE (51-64-9) & AMPHETAMINE SULFATE (60-13-9)); component of Biphetamine; EINECS 206-096-2; alpha-Methylphenethylamine; (+)-.alpha.-Methylphenylethylamine; Phenethylamine, .alpha.-methyl-, d-; Phenethylamine, alpha-methyl, (+-)-; Novydrine; 60-15-1; D07445; AI3-02438; Mecodrin; Anfetamina [Spanish]; C9H13N; Amphetamine Sulfate (2:1); MolPort-001-783-432; Adipan; NSC170999; Mydrial; Benzolone; beta-Phenylisopropylamin; Desoxynorephedrin; 1-Phenyl-2-propylamine; EINECS 200-458-3; Oprea1_447423; 1-phenylpropan-2-amine; Thyramine; 2-Amino-1-phenylpropane; 1-Phenyl-2-propanamine    
Trade NameAdderall; Vyvanse; Dexedrine    
CompanyShire Pharmaceuticals    
IndicationAttention deficit hyperactivity disorderApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassCentral Nervous System Stimulants    
CAS NumberCAS 300-62-9
FormularC9H13N    
PubChem Compound IDCID 3007.    
PubChem Substance IDSID 9717.    
ChEBI2679;    
SuperDrug ATC IDN06BA01;    
SuperDrug CAS ID000300629;    
TargetN-methyl-D-aspartate (NMDA) receptorAntagonist[2]
Ref 1Pharmacotherapy for adult ADHD. J Clin Psychiatry. 2009 May;70(5):e12. To Reference
Ref 2J Pharmacol Exp Ther. 2002 Mar;300(3):1008-16.Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543